- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00303472 | Completed Has Results |
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
72 | All | 18 Years and older (Adult, Senior) | NCT00303472 | 20050159 | February 2006 | May 2008 | May 2008 | March 17, 2006 | December 16, 2013 | November 19, 2010 |